Saturday, December 21, 2024
HomeTagsRadiopharmaceutical Platform

Radiopharmaceutical Platform

Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio

Bristol Myers Squibb and RayzeBio, Inc., announced a definitive merger agreement under which Bristol Myers Squibb will acquire RayzeBio for $62.50 per share in...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics